Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 September 2005

Parental consanguinity and risk of breast cancer: A population-based case-control study

Srdjan Denic, Abdulbari Bener, Sufyan Sabri, Falah Khatib, Jadranka Milenkovic

Med Sci Monit 2005; 11(9): CR415-419 :: ID: 428448

Abstract

Background: An estimated 600 million people in the world have consanguineousparents. The effect of consanguinity on the risk of breast cancer is uncertain. The objective of thiscase-control study was to examine whether parental consanguinity and different levels of inbreeding affectthe risk and pathology characteristics of breast cancer. Material/Methods: Over a 36-month period, consecutivefemale breast cancer patients were recruited in the main cancer hospital in the United Arab Emirates.All were locally born Arabs with a tissue diagnosis of breast cancer. The controls were locally bornArabs without breast cancer matched to cases by sex, age, and residence. The coefficient of inbreeding(F) of both groups was determined from information they provided about their parents' kinship. Results:The mean age of the 72 patients and 187 controls was 48.6 years (range: 25-86) and 48.5 years (range:25-82), respectively (P=0.46). Consanguinity rates of the patients and controls were 29.2% and 28.9%(P=0.96) and the coefficients of inbreeding were 0.0117 and 0.0167 (P=0.21), respectively. More closelyinbred women (F>/=0.0625) were less frequent among patients than controls, but the difference was notstatistically significant (P=0.12). The rates of pathological stage of disease, tumor histologies, andtumor grades were similar between more and less inbred patients. Conclusions: Parental consanguinityin Arabs, even when a marriage is between first cousins or double first cousins, was not associated withan altered risk of breast cancer.

Keywords: Aged, 80 and over, Breast Neoplasms - genetics, Case-Control Studies, Consanguinity, Prospective Studies, Risk Factors, United Arab Emirates

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750